Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dismissing Requests of World’s Gelatin Makers, FDA Asks USP to Add Tests for Melamine to Monograph

This article was originally published in The Gold Sheet

Executive Summary

Undeterred by arguments from gelatin manufacturers that there is no economic motivation to put melamine in gelatin, FDA asks USP to require additional testing for the potential adulterant.


Related Content

China Drug Safety Remains Front and Center In Chromium Capsule Scandal
FDA Identifies Excipients At Risk for Potential Melamine Contamination
Heparin Adulteration Triggered Pharmaceutical Identity Crisis





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts